Status:
COMPLETED
Diabetes Journey: An Adolescent Adherence Barriers Intervention
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborating Sponsors:
University of Florida
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Type 1 Diabetes
Adherence, Patient
Eligibility:
All Genders
13-17 years
Phase:
NA
Brief Summary
The purpose of this study is to examine the feasibility, acceptability, and preliminary efficacy of a web-based intervention addressing adherence barriers in adolescents with T1D.
Detailed Description
Type 1 diabetes (T1D) treatment adherence is complex and involves glucose monitoring, counting carbohydrates, and intensive insulin delivery via injections or insulin pump in response to food intake, ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- T1D diagnosis \>1 year
- Adolescents with T1D ages 13-17
- Elevations on the Barriers to Diabetes Adherence questionnaire (scores of ≥3 of 53 for the Stress/Burnout and/or Time Pressure/Planning subscales) based on their previous clinic visit scores
- Ability to read/speak English (all measures are in English)
- Exclusion Criteria
- Diagnosis of significant developmental disorders (e.g., autism spectrum disorder, moderate/severe developmental or intellectual disability)
- Comorbid medical diagnoses (e.g., cystic fibrosis, asthma) with the exception of endocrine disorders (e.g., Celiac disease, thyroid)
- No use of/plans to use non-insulin medication for blood glucose control
Exclusion
Key Trial Info
Start Date :
August 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2024
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT04404556
Start Date
August 10 2020
End Date
March 31 2024
Last Update
July 15 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32610-0165
2
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229